What is CBL & Associates Properties, Inc.'s earnings per share (EPS)?

CBL & Associates Properties, Inc. (CBL) reported diluted earnings per share of $4.34 for fiscal year 2025. This represents a 132.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CBL & Associates Properties, Inc. (CBL) Financials

CBL

Trailing 12 months to June 30, 2026

Revenue $588.1M +9.0% YoY

Net Income $217.3M +230.7% YoY

EPS (Diluted) $6.89 +229.7% YoY

Operating Cash Flow $282.9M +36.5% YoY

Market Cap $1.5B as of Oct 10, 2026

Price / Sales 2.6x on $588.1M revenue, trailing 12 months to June 30, 2026

Price / Earnings 6.9x on $217.3M net income, trailing 12 months to June 30, 2026

Price / Book 3.5x on $427.4M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 7, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CBL SEC filings page.

CBL & Associates Properties, Inc. (CBL) reported $588.1M in revenue over the twelve months to Jun 30, 2026, up 9.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CBL FY2025 2026-10-03

Reported profit is improving, but the property business remains heavily debt-funded and cash generation is doing more work than earnings.

FY2025 operating cash flow was $250M, while investing and financing together used nearly the same amount. That pattern, alongside positive net income, suggests reported cash generation was being recycled into property activity and capital structure rather than simply flowing through to equity holders.

Debt-to-equity was 5.8x in FY2025, making the balance sheet predominantly debt-funded and leaving equity comparatively thin. The ratio improved from 6.8x in FY2024, but leverage remains structurally elevated, so changes in asset values or financing costs can disproportionately affect shareholders’ equity.

Interest expense rose from $154M in FY2024 to $176M in FY2025, yet net income more than doubled, showing that the earnings improvement was not driven by cheaper financing. Depreciation was $165M in FY2025, so net income and operating cash flow measure different economic layers: accounting allocation versus cash produced by operations.

Financial Health Signals

Financial Health Score 54/100

Scored as: REITs peer group

Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of CBL & Associates Properties, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

FFO Margin

FFO Margin measures funds from operations against revenue, and funds from operations is net income with property depreciation added back, since a building written down a little further every year on paper is often worth more rather than less. CBL & Associates Properties, Inc. scores 73/100 on it among other REITs.

FFO Growth

FFO Growth follows the three-year path of funds from operations, which is net income with property depreciation added back. CBL & Associates Properties, Inc. scores 80/100 on it among other REITs.

Leverage

Not available for CBL & Associates Properties, Inc., and counted as zero in the overall score.

Interest Cov.

Not available for CBL & Associates Properties, Inc., and counted as zero in the overall score.

AFFO Margin

AFFO Margin takes funds from operations, subtracts the spending a REIT needs just to keep its properties in working order, and measures what is left against revenue. CBL & Associates Properties, Inc. scores 75/100 on it among other REITs.

Dividend Cov.

Dividend coverage measures funds from operations against the dividends actually paid, and a figure above 1 means the payout came out of operations. CBL & Associates Properties, Inc. scores 93/100 on it among other REITs.

Piotroski F-Score Partial

6/7

CBL & Associates Properties, Inc. passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.84x

For every $1 of reported earnings, CBL & Associates Properties, Inc. generates $1.84 in operating cash flow ($249.7M OCF vs $136.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$146.5M

YoY+4.0%

QoQ+0.4%

5Y CAGR+1.4%

10Y CAGR-5.4%

CBL & Associates Properties, Inc. generated $146.5M in revenue in Q2 2026. This represents an increase of 4.0% from the same quarter a year earlier. Against the prior quarter it is up 0.4%.

Net Income

$46.4M

YoY+1583.4%

QoQ-0.1%

10Y CAGR-3.0%

CBL & Associates Properties, Inc. reported $46.4M in net income in Q2 2026. This represents an increase of 1583.4% from the same quarter a year earlier. Against the prior quarter it is down 0.1%.

EPS (Diluted)

$1.47

YoY+1737.5%

QoQ-0.7%

CBL & Associates Properties, Inc. earned $1.47 per diluted share (EPS) in Q2 2026. This represents an increase of 1737.5% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$101.3M

YoY+1.0%

QoQ-17.5%

5Y CAGR-6.8%

10Y CAGR+17.0%

CBL & Associates Properties, Inc. held $101.3M in cash against $2.0B in long-term debt as of Q2 2026.

Shares Outstanding

31M

YoY0.0%

QoQ0.0%

5Y CAGR-30.9%

10Y CAGR-15.7%

CBL & Associates Properties, Inc. had 31M shares outstanding in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Net Margin

31.7%

YoY+29.8pp

QoQ-0.1pp

5Y change+38.2pp

10Y change+7.0pp

CBL & Associates Properties, Inc.'s net profit margin was 31.7% in Q2 2026, showing the share of revenue converted to profit. This is up 29.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Return on Equity

10.9%

YoY+9.9pp

QoQ-0.8pp

5Y change+12.7pp

10Y change+5.9pp

CBL & Associates Properties, Inc.'s ROE was 10.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 9.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

QoQ-100.0%

CBL & Associates Properties, Inc. repurchased no shares in Q2 2026. Against the prior quarter it is down 100.0%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

CBL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CBL quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$588.1M	$578.4M+12.2%	$515.6M-3.7%	$535.3M-4.9%	$563.0M	N/A	$575.9M-25.1%	$768.7M-10.5%	$858.6M-7.4%	$927.3M-9.8%	$1.0B-2.5%	$1.1B-0.5%	$1.1B+0.7%	$1.1B+5.1%	$1.0B-4.6%	$1.1B
SG&A Expenses	$66.5M	$69.0M+2.7%	$67.3M+5.0%	$64.1M-4.7%	$67.2M	N/A	$53.4M-16.8%	$64.2M+4.3%	$61.5M+5.2%	$58.5M-7.7%	$63.3M+2.0%	$62.1M+23.6%	$50.3M+2.9%	$48.9M-4.7%	$51.3M+14.5%	$44.8M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$232.6M-8.3%	$253.6M-8.6%	$277.6M-26.0%	$375.1M+13.4%	$330.8M-10.6%	$369.9M+3.1%	$358.7M
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$531.7M-2.7%	$546.3M-5.3%	$576.7M-13.5%	$666.4M+9.3%	$609.7M-2.5%	$625.4M-0.8%	$630.2M
Interest Expense	$170.4M	$176.0M+13.9%	$154.5M-10.7%	$172.9M-20.4%	$217.3M	N/A	$200.7M-2.7%	$206.3M-6.3%	$220.0M+0.6%	$218.7M+1.1%	$216.3M-5.7%	$229.3M-4.4%	$239.8M+3.4%	$231.9M-4.3%	$242.4M-9.3%	$267.1M
Income Tax	-$11K	$475K-55.0%	$1.1M+18.0%	$894K-71.0%	$3.1M	N/A	$16.8M+434.0%	$3.2M+303.3%	-$1.6M+19.8%	-$1.9M+6.3%	-$2.1M-170.1%	$2.9M-34.6%	$4.5M+244.8%	$1.3M-7.1%	$1.4M+621.9%	-$269K
Net Income	$217.3M	$136.0M+130.6%	$59.0M+800.9%	$6.5M+107.0%	-$93.5M	N/A	-$295.1M-171.3%	-$108.8M-38.4%	-$78.6M-165.0%	$120.9M-30.0%	$172.9M+67.2%	$103.4M-52.8%	$219.2M+157.2%	$85.2M-35.3%	$131.6M-1.7%	$133.9M
EPS (Basic)	N/A	$4.41+135.8%	$1.87+1000.0%	$0.17+105.3%	-$3.20	N/A	-$1.75	N/A	-$0.72-263.6%	$0.44-41.3%	$0.75+120.6%	$0.34-66.7%	$1.02+325.0%	$0.24-55.6%	$0.54-12.9%	$0.62
EPS (Diluted)	$6.89	$4.34+132.1%	$1.87+1000.0%	$0.17+105.3%	-$3.20	N/A	-$1.75	N/A	N/A	$0.44-41.3%	$0.75+120.6%	$0.34-66.7%	$1.02	$0.24-55.6%	$0.54-12.9%	$0.62
Diluted Shares (Avg)	N/A	31M-0.4%	31M-1.1%	31M+4.2%	30M	N/A	190,277	N/A	N/A	N/A	N/A	N/A	N/A	N/A	155M+4.4%	148M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$146.5M+4.0%	$146.0M+3.0%	$156.4M+18.8%	$139.3M+11.3%	$140.9M+8.7%	$141.8M+9.8%	$131.7M-5.7%	$125.1M-3.3%
SG&A Expenses	$14.8M-2.7%	$18.6M-10.2%	$15.4M-7.5%	$17.8M+15.5%	$15.2M+2.4%	$20.7M+1.4%	$16.6M+16.3%	$15.4M+7.0%
Interest Expense	$42.7M-2.8%	$39.9M-9.8%	$43.0M+18.1%	$44.8M+15.3%	$44.0M+11.6%	$44.2M+11.1%	$36.4M-13.9%	$38.8M-9.4%
Income Tax	$642K+74.0%	-$1.2M-161.1%	$529K+165.8%	$48K-86.8%	$369K-43.2%	-$471K-198.1%	$199K+140.9%	$364K-71.2%
Net Income	$46.4M+1583.4%	$46.5M+428.9%	$49.0M+29.0%	$75.4M+365.7%	$2.8M-41.8%	$8.8M+17478.0%	$38.0M+221.5%	$16.2M+22.1%
EPS (Basic)	$1.50+1775.0%	$1.50+455.6%	$1.60+31.1%	$2.44+369.2%	$0.08-42.9%	$0.27+2800.0%	$1.22+238.9%	$0.52+26.8%
EPS (Diluted)	$1.47+1737.5%	$1.48+448.1%	$1.56+27.9%	$2.38+357.7%	$0.08-42.9%	$0.27+2800.0%	$1.22+238.9%	$0.52+26.8%
Diluted Shares (Avg)	31M+0.6%	31M-0.1%	N/A	31M+1.8%	31M-1.3%	31M-2.7%	N/A	31M+98146.3%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

CBL Balance Sheet

CBL quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$2.7B-0.7%	$2.7B+14.2%	$2.4B-10.2%	$2.7B-9.1%	$2.9B-33.7%	$4.4B-3.9%	$4.6B-13.5%	$5.3B-6.4%	$5.7B-6.5%	$6.1B-5.8%	$6.5B-1.8%	$6.6B-2.5%	$6.8B-4.5%	$7.1B+5.5%	$6.7B
Cash & Equivalents	$42.3M+3.7%	$40.8M+19.3%	$34.2M-23.5%	$44.7M-73.6%	$169.6M+174.4%	$61.8M+88.3%	$32.8M+30.5%	$25.1M-23.0%	$32.6M+72.2%	$19.0M-48.6%	$36.9M-2.8%	$37.9M-42.1%	$65.5M-16.3%	$78.2M+39.5%	$56.1M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$46.5M+2.0%	$45.6M+5.0%	$43.4M+6.9%	$40.6M+61.3%	$25.2M-75.7%	$103.7M+37.7%	$75.3M-3.3%	$77.8M-6.9%	$83.6M-11.7%	$94.7M+8.5%	$87.3M+7.3%	$81.3M+1.8%	$79.9M+1.2%	$79.0M+6.5%	$74.2M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$2.4B-2.9%	$2.4B+17.3%	$2.1B-10.2%	$2.3B-9.2%	$2.5B-34.9%	$3.9B+4.1%	$3.8B-12.7%	$4.3B-3.5%	$4.5B-6.0%	$4.7B-6.1%	$5.1B+0.5%	$5.0B-3.1%	$5.2B+1.7%	$5.1B+6.5%	$4.8B
Long-Term Debt	$2.2B-1.9%	$2.2B+17.1%	$1.9B-5.6%	$2.0B+10.3%	$1.8B+53.0%	$1.2B-66.4%	$3.5B-12.8%	$4.0B-4.4%	$4.2B-5.3%	$4.5B-5.2%	$4.7B+0.6%	$4.7B-3.6%	$4.9B+2.4%	$4.7B+5.7%	$4.5B
Total Equity	$374.9M+15.9%	$323.5M-4.6%	$339.3M-8.4%	$370.5M-6.5%	$396.2M-25.5%	$531.8M-34.0%	$806.3M-16.4%	$964.1M-15.4%	$1.1B-7.2%	$1.2B-4.4%	$1.3B-8.6%	$1.4B+0.1%	$1.4B+5.7%	$1.3B+5.2%	$1.3B
Retained Earnings	-$313.0M+15.8%	-$371.8M+2.3%	-$380.4M-12.2%	-$338.9M-123.7%	-$151.5M+89.6%	-$1.5B-25.4%	-$1.2B-15.5%	-$1.0B-20.3%	-$836.3M-12.7%	-$742.1M-7.7%	-$689.0M-21.6%	-$566.8M+0.7%	-$570.8M-25.8%	-$453.6M-13.5%	-$399.6M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$2.6B+1.3%	$2.6B+0.8%	$2.7B-0.7%	$2.7B+21.5%	$2.6B+12.1%	$2.6B+12.0%	$2.7B+14.2%	$2.2B-7.7%
Cash & Equivalents	$101.3M+1.0%	$122.7M+311.6%	$42.3M+3.7%	$52.6M-19.2%	$100.3M+73.9%	$29.8M-48.3%	$40.8M+19.3%	$65.1M+88.7%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$41.8M+17.4%	$39.3M+3.8%	$46.5M+2.0%	$37.6M-5.7%	$35.6M-6.7%	$37.9M+0.8%	$45.6M+5.0%	$39.8M+7.9%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$2.2B-4.8%	$2.3B-3.5%	$2.4B-2.9%	$2.4B+22.6%	$2.3B+15.0%	$2.3B+15.4%	$2.4B+17.3%	$1.9B-7.5%
Long-Term Debt	$2.0B-4.9%	$2.1B-3.3%	$2.2B-1.9%	$2.2B+22.9%	$2.1B+15.5%	$2.2B+15.6%	$2.2B+17.1%	$1.8B-6.6%
Total Equity	$427.4M+47.7%	$398.0M+34.9%	$374.9M+15.9%	$351.4M+14.0%	$289.4M-6.3%	$295.0M-9.0%	$323.5M-4.6%	$308.3M-8.9%
Retained Earnings	-$258.7M+36.9%	-$285.8M+28.6%	-$313.0M+15.8%	-$348.2M+12.4%	-$409.8M-2.1%	-$400.2M-1.8%	-$371.8M+2.3%	-$397.5M-4.5%

Not reported in any period shown, so not listed: Current Assets, Inventory, Goodwill, Current Liabilities, Non-Current Liabilities.

CBL Cash Flow Statement

CBL quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$282.9M	$249.7M+23.5%	$202.2M+10.2%	$183.5M-11.9%	$208.2M	N/A	$133.4M-51.2%	$273.4M-27.5%	$377.2M-12.4%	$430.4M	N/A	N/A	N/A	N/A	$481.5M+9.0%	$441.8M
Depreciation & Amortization	N/A	$165.2M+17.5%	$140.6M-26.2%	$190.5M-25.7%	$256.3M	N/A	$215.0M-16.6%	$257.7M-9.7%	$285.4M-4.6%	$299.1M+2.2%	$292.7M-2.1%	$299.1M+2.7%	$291.3M+4.4%	$278.9M+9.2%	$255.5M-5.9%	$271.5M
Stock-Based Compensation	N/A	$16.7M+12.2%	$14.9M+15.0%	$13.0M+9.2%	$11.9M	N/A	$5.8M+21.7%	$4.8M-11.2%	$5.4M-7.0%	$5.8M+23.7%	$4.7M+9.2%	$4.3M+24.5%	$3.4M+28.3%	$2.7M-28.3%	$3.7M+109.8%	$1.8M
Investing Cash Flow	-$161.6M	-$115.1M-277.1%	$65.0M+3721.6%	$1.7M+101.1%	-$156.7M	N/A	-$280.4M-1240.5%	$24.6M+189.5%	-$27.5M+63.8%	-$75.8M	N/A	N/A	N/A	N/A	-$246.7M-792.3%	-$27.6M
Financing Cash Flow	-$123.2M	-$135.4M+42.7%	-$236.5M-15.9%	-$204.1M-40.0%	-$145.8M	N/A	$209.7M+170.7%	-$296.4M+17.8%	-$360.4M-2.5%	-$351.5M	N/A	N/A	N/A	N/A	-$212.7M+48.0%	-$409.0M
Dividends Paid	$66.3M	$77.1M+53.1%	$50.4M-57.4%	$118.1M+394.7%	$23.9M	N/A	N/A	$26.0M-81.2%	$137.8M-24.0%	$181.3M	N/A	N/A	N/A	N/A	$133.7M+8.7%	$123.0M
Share Buybacks	$19.4M	$18.1M-50.5%	$36.5M+3187.5%	$1.1M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$80.3M+17.6%	$52.9M+67.0%	$80.2M+73.5%	$69.6M+13.9%	$68.3M+6.3%	$31.7M+3.1%	$46.2M-6.4%	$61.1M+22.3%
Depreciation & Amortization	$36.3M-8.6%	$38.1M-16.3%	$40.0M+26.8%	$39.9M+23.4%	$39.7M+2.7%	$45.5M+19.7%	$31.6M-25.5%	$32.3M-28.4%
Stock-Based Compensation	N/A	$2.4M-40.8%	N/A	N/A	N/A	$4.0M+8.5%	N/A	N/A
Investing Cash Flow	-$31.7M-168.0%	$83.3M+61.9%	-$41.4M-658.1%	-$171.8M-484.2%	$46.6M+434.8%	$51.4M+91.9%	$7.4M+145.2%	$44.7M+690.4%
Financing Cash Flow	-$58.7M-75.0%	-$76.4M+32.8%	-$47.8M-15.8%	$59.7M+156.6%	-$33.5M+7.7%	-$113.8M-113.2%	-$41.3M-39.6%	-$105.5M-191.0%
Dividends Paid	$24.8M+100.1%	$13.9M-62.5%	$13.7M+11.6%	$13.9M+10.9%	$12.4M-2.3%	$37.1M+188.4%	$12.3M+2.5%	$12.5M+4.2%
Share Buybacks	$0	$1.3M	$13.9M+11.0%	$4.2M-47.6%	$0-100.0%	$0-100.0%	$12.5M+4325.8%	$7.9M

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

CBL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CBL quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	25.1%+0.4pp	24.7%-1.6pp	26.3%-9.1pp	35.4%+4.0pp	31.4%-5.5pp	36.9%+2.8pp	34.1%
Net Margin	23.5%+12.1pp	11.4%+10.2pp	1.2%+17.8pp	-16.6%	N/A	-51.2%-37.1pp	-14.1%-5.0pp	-9.2%-22.2pp	13.0%-3.8pp	16.8%+7.0pp	9.8%-10.9pp	20.7%+12.6pp	8.1%-5.0pp	13.1%+0.4pp	12.7%
Return on Equity	36.3%+18.0pp	18.2%+16.3pp	1.9%+27.2pp	-25.2%	N/A	-55.5%-42.0pp	-13.5%-5.3pp	-8.2%-18.8pp	10.6%-3.5pp	14.1%+6.0pp	8.0%-7.5pp	15.6%+9.5pp	6.1%-3.8pp	9.9%-0.7pp	10.6%
Return on Assets	5.0%+2.8pp	2.1%+1.9pp	0.3%+3.8pp	-3.5%	N/A	-6.6%-4.3pp	-2.4%-0.9pp	-1.5%-3.6pp	2.1%-0.7pp	2.8%+1.2pp	1.6%-1.7pp	3.3%+2.1pp	1.3%-0.6pp	1.9%-0.1pp	2.0%
Debt-to-Equity	5.79-1.0x	6.84+1.3x	5.57+0.2x	5.40+0.8x	4.58+2.3x	2.23-2.1x	4.37+0.2x	4.19+0.5x	3.71+0.1x	3.630.0x	3.67+0.3x	3.33-0.1x	3.46-0.1x	3.570.0x	3.55
Asset Turnover	0.210.0x	0.190.0x	0.220.0x	0.21	N/A	0.130.0x	0.170.0x	0.160.0x	0.160.0x	0.170.0x	0.160.0x	0.160.0x	0.160.0x	0.140.0x	0.16

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	31.7%+29.8pp	31.9%+25.7pp	31.3%+2.5pp	54.2%+41.2pp	2.0%-1.7pp	6.2%+6.2pp	28.8%+20.4pp	13.0%+2.7pp
Return on Equity	10.9%+9.9pp	11.7%+8.7pp	13.1%+1.3pp	21.5%+16.2pp	0.9%-0.6pp	3.0%+3.0pp	11.7%+8.3pp	5.3%+1.3pp
Return on Assets	1.8%+1.7pp	1.8%+1.4pp	1.8%+0.4pp	2.8%+2.0pp	0.1%-0.1pp	0.3%+0.3pp	1.4%+0.9pp	0.7%+0.2pp
Debt-to-Equity	4.76-2.6x	5.22-2.1x	5.79-1.0x	6.21+0.4x	7.39+1.4x	7.29+1.6x	6.84+1.3x	5.76+0.1x
Asset Turnover	0.060.0x	0.060.0x	0.060.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.060.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
CBL & Associates Properties, Inc. CBL	FY2025	$578.4M	$136.0M	23.5%	$1.5B	54/100
Saul Centers, Inc. BFS	FY2025	$289.8M	$37.5M	12.9%	$741.5M	63/100
Alexander's Inc. ALX	FY2025	$213.2M	$28.2M	13.2%	$1.2B	26/100
Getty Realty Corp. GTY	FY2025	$221.7M	$79.2M	35.7%	$1.7B	68/100
Alexander & Baldwin, Inc. ALEX	FY2025	$206.7M	$64.7M	31.3%	$1.5B	65/100
Whitestone REIT WSR	FY2025	$160.9M	$49.9M	31.0%	$976.0M	56/100

Where CBL & Associates Properties, Inc. Ranks

Frequently Asked Questions

What is CBL & Associates Properties, Inc.'s annual revenue?

CBL & Associates Properties, Inc. (CBL) reported $578.4M in total revenue for fiscal year 2025. This represents a 12.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CBL & Associates Properties, Inc.'s revenue growing?

CBL & Associates Properties, Inc. (CBL) revenue grew by 12.2% year-over-year, from $515.6M to $578.4M in fiscal year 2025.

Is CBL & Associates Properties, Inc. profitable?

Yes, CBL & Associates Properties, Inc. (CBL) reported a net income of $136.0M in fiscal year 2025, with a net profit margin of 23.5%.

How much debt does CBL & Associates Properties, Inc. have?

As of fiscal year 2025, CBL & Associates Properties, Inc. (CBL) had $42.3M in cash and equivalents against $2.2B in long-term debt.

What is CBL & Associates Properties, Inc.'s net profit margin?

CBL & Associates Properties, Inc. (CBL) had a net profit margin of 23.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CBL & Associates Properties, Inc.'s return on equity (ROE)?

CBL & Associates Properties, Inc. (CBL) has a return on equity of 36.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CBL & Associates Properties, Inc.'s operating cash flow?

CBL & Associates Properties, Inc. (CBL) generated $249.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CBL & Associates Properties, Inc.'s total assets?

CBL & Associates Properties, Inc. (CBL) had $2.7B in total assets as of fiscal year 2025, including both current and long-term assets.

Does CBL & Associates Properties, Inc. buy back shares?

Yes, CBL & Associates Properties, Inc. (CBL) spent $18.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does CBL & Associates Properties, Inc. have outstanding?

CBL & Associates Properties, Inc. (CBL) had 31M shares outstanding as of fiscal year 2025.

What is CBL & Associates Properties, Inc.'s debt-to-equity ratio?

CBL & Associates Properties, Inc. (CBL) had a debt-to-equity ratio of 5.79 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CBL & Associates Properties, Inc.'s return on assets (ROA)?

CBL & Associates Properties, Inc. (CBL) had a return on assets of 5.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CBL & Associates Properties, Inc.'s P/E ratio?

CBL & Associates Properties, Inc. (CBL) trades at 6.9x earnings, its market capitalization divided by net income of $217.3M net income, trailing 12 months to June 30, 2026. The market capitalization is $1.5B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is CBL & Associates Properties, Inc.'s price-to-sales ratio?

CBL & Associates Properties, Inc. (CBL) trades at 2.6x sales, its market capitalization divided by revenue of $588.1M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.5B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is CBL & Associates Properties, Inc.'s Piotroski F-Score?

CBL & Associates Properties, Inc. (CBL) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CBL & Associates Properties, Inc.'s earnings high quality?

CBL & Associates Properties, Inc. (CBL) has an earnings quality ratio of 1.84x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is CBL & Associates Properties, Inc.?

CBL & Associates Properties, Inc. (CBL) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its REITs peer group. The score is a 0-100 composite of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.